Podcast appearances and mentions of Scott Gottlieb

On this episode, Jason and Matt are joined by their close friend Luis Fernando Mises, along with Jennifer Gillis and Misty Brown, two tireless advocates with the American Kratom Association. Together, we dive deep into the criminalization of kratom — from Louisiana's looming ban to the federal government's quiet war on natural medicine. Luis Fernando Mises is a consultant who teaches leadership across the U.S., a yoga and meditation teacher, a student of Austrian economics, a statesman with the Libertarian Party, a curandero, an entrepreneur, and a family man. He also runs a successful kratom business and brings rare clarity on both the plant and the marketplace. Misty Brown is a fierce kratom advocate and consumer who uses her voice to protect whole-leaf kratom and keep it legal and safe. Her work is personal — helping others fight addiction, chronic pain, anxiety, and depression. Jennifer Gillis has lived with chronic pain for 19 years. After finding real relief through kratom six years ago, she became a dedicated advocate, educator, and truth-teller who supports efforts to keep kratom accessible for all. We begin with the Louisiana ban, where Misty reveals troubling claims of bribery between a sheriff and a rehab clinic pushing the ban behind closed doors. From there, we move to the federal level — breaking down the media's obsession with 7-OH (a lab-concentrated alkaloid being falsely labeled as “kratom”) and how it's fueling disinformation, addiction, and panic. Luis gives clear and grounded advice on avoiding dangerous gas station extracts and choosing safe, whole-leaf kratom instead. We then explore the FDA's alliance with Big Pharma, RFK Jr.'s recent crackdown on 7-OH, and how this could pave the way for a nationwide ban. We dive into Scott Gottlieb's ties to GlaxoSmithKline, the push for synthetic patents, and the blatant monopolization of nature. Then we bring it home with a hard look at the horrors of prohibition through the heartbreaking stories of Shaina Brown and Marshall Price, two innocent people whose lives were upended — and in one case, ended — over this plant. We close with each guest offering real solutions and a final word of encouragement to the millions of Americans who use kratom safely, responsibly, and with purpose. This is a must-listen for anyone who cares about bodily autonomy, plant medicine, and the rising tide of pharmaceutical control. (Length: 1:08:44) Donate/Subscribe to TFTP: https://tftpsubdomain.wpengine.com/tftp-membership/  Jason's 'Know Your Right's 1-Hour Online Seminar: https://www.jasonbassler.com/book-online Sign the petition: https://www.protectkratom.org/  American Kratom Association: https://www.americankratom.org/  Facebook: https://www.facebook.com/emancipatedhumanWebsite: https://emancipatedhuman.com/Kratom: https://bestdamnkratom.com/Contact Luis at his Website Here: https://luisfernandomises.com/

President Trump has ratcheted up tariffs for dozens of countries set to take effect next week. Apple reported its greatest revenue growth in years, Microsoft's market cap topped $4 trillion after its earnings report, and Amazon's disappointing earnings forecast overshadowed its solid results. Software design company Figma more than tripled in its NYSE debut; bankers and CEOs are interpreting this performance as a sign that the IPO window is officially open for tech companies this year. Former FDA Commissioner Dr. Scott Gottlieb discusses the new direction of his former agency under leadership of the sitting commissioner, Dr. Marty Makary. Top of mind for Dr. Gottlieb: the body's large number of scientist departures. Lead Edge Capital Founding Partner Mitchell Green discusses the toll the Silicon Valley battle for AI talent is taking on private company share dilution. Plus, the July jobs report came in weaker than economists expected, and it brought some downward revisions for the previous month.  Megan Cassella - 04:12Dr. Scott Gottlieb - 21:51Mitchell Green - 34:14 In this episode:Dr. Scott Gottlieb, @ScottGottliebMDMegan Cassella, @mmcassellaJoe Kernen, @JoeSquawk Becky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

This week on Face the Nation, President Trump turns his focus to getting his Big Beautiful Bill through Congress after a week of foreign policy wins. President Trump warned his party Saturday that refusing to support his signature domestic spending bill would be an act of the "ultimate betrayal.”  We'll discuss the legislation's path forward and the surprising string of foreign policy successes last week with the top Democrat on the Senate Intelligence Committee, Virginia's Mark Warner. Texas House Republican Michael McCaul also weighs in. Then, what's next when it comes to Iran?  We'll talk with the head of the IAEA, the watchdog agency who monitors nuclear capabilities in Iran, Rafael Mariano Grossi and speak to Iran's ambassador to the U.N., Amir Saeid Iravani. Finally, former FDA commissioner Dr. Scott Gottlieb will join us for a reality check on new developments with vaccines and health policy. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

President Trump continues to pressure Fed Chair Jay Powell to lower interest rates. Sen. Elizabeth Warren (D-Mass.) reacts to Powell's testimony and the Fed's next move. Warren discusses the impact of tariffs on inflation and the state of the Democratic Party. Meanwhile, Health Secretary Robert F. Kennedy Jr.'s revamped vaccine panel has begun reviewing long-approved U.S. vaccines. Former FDA Commissioner Dr. Scott Gottlieb shares his thoughts on the CDC's new advisory board and the future of vaccine policy. Plus, the latest on President Trump's legal battle with Paramount and are crypto mortgages in our future? Sen. Elizabeth Warren - 16:28Dr. Scott Gottlieb - 35:16 Sen. Elizabeth Warren, @SenWarrenDr. Scott Gottlieb, @ScottGottliebMDBecky Quick, @BeckyQuickJoe Kernen, @JoeSquawkZach Vallese, @zachvallese

President Trump has left the G7 meeting early, citing his priority monitoring the Israel-Iran conflict. Steve Eisman famously called and profited from the housing crisis, and today the Wall Street watcher is optimistic on the conflict in the Middle East–at least when it comes to the markets. Former FDA Commissioner Dr. Scott Gottlieb weighs in on the price of cutting health and research funding, as well as his outlook for the innovation pipeline in the U.S. Plus, drama might be brewing between OpenAI and Microsoft, and crypto billionaire Justin Sun is taking Tron public.  Steve Eisman 11:59Dr. Scott Gottlieb 22:54 In this episode:Steve Eisman, @EismanPlaybookDr. Scott Gottlieb, @ScottGottliebMDBecky Quick, @BeckyQuickJoe Kernen, @JoeSquawkKatie Kramer, @Kramer_Katie

Health reporter Martha Rosenberg discusses her article, "Conflicts of interest are eroding trust in U.S. health agencies." Martha outlines how faith in government health bodies like the FDA and CDC has plummeted due to escalating conflicts of interest, tracing some concerns back to the 1992 Prescription Drug User Fee Act (PDUFA), which allowed drugmakers to fund aspects of the drug approval process. She points to a pattern of FDA commissioners, such as Dr. Scott Gottlieb, Dr. Robert Califf, and Dr. Margaret Hamburg, having significant financial ties to the pharmaceutical industry, and notes the concerning practice of drug trials being funded by the manufacturers of the drugs under investigation. Martha also examines the CDC Foundation, which accepts private donations, and cites several CDC directors, including Dr. Brenda Fitzgerald, Dr. Tom Frieden, Dr. Julie Gerberding, and Dr. Robert Redfield, who faced scrutiny over alleged conflicts or ethical issues. The conversation delves into the pervasive influence of pharmaceutical lobbying on Congress and the increasing tendency of medical journals to publish industry-funded research, highlighting the danger these interwoven interests pose to public trust and patient well-being. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise and it's part of Microsoft Cloud for Healthcare–and it's built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

The Trump administration is investigating semiconductors and pharmaceutical ingredients, the first steps toward tariffs in those industries. Former FDA Commissioner and board member at Pfizer and Illumina Dr. Scott Gottlieb shares his concern that if costs get any higher for generics like heparin, hydrocortisone, and amoxicillin, drugmakers might stop manufacturing them. Dr. Gottlieb explains America's pharma supply chain through China and India, as well as the thin margins on some of the most commonly used drugs in the United States. The Trump administration ordered a freeze on $2.2B grants to Harvard after the university rejected the White House's demands for changes, including to DEI programs. The move has sparked another debate about free speech on higher education campuses. Plus, the Chinese government has reportedly ordered Chinese airlines to stop buying Boeing aircraft, and DOGE cuts in DC have hit the workforce in Virginia. Governor Glenn Youngkin (R-VA) is still optimistic about his state's future.  Glenn Youngkin - 21:21Dr. Scott Gottlieb - 39:36 In this episode:Glenn Youngkin, @GovernorVADr. Scott Gottlieb, @ScottGottliebMDKelly Evans, @KellyCNBCJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

Are movies ditching the woke ideology? Who are the people in the company. The importance of manufacturing and supply lines. Scott Gottlieb is demonizing RFK after Scott pushed mass covid vaccines. Did Bill Burr get a fat paycheck to carry water for Democrats? See omnystudio.com/listener for privacy information.

The FDA's top vaccine official has resigned from the agency, citing what he called “misinformation and lies” from HHS Secretary Robert F. Kennedy Jr. about vaccinations. Former FDA Commissioner Dr. Scott Gottlieb discusses the official's departure, the U.S. measles outbreak, and the importance of bolstering public trust in science and health systems. Former antitrust assistant attorney general Makan Delrahim discusses the future of M&A under the second Trump administration, and investors and business owners are bracing for President Trump's tariffs set to take effect on April 3. Plus, President Trump has once again floated the idea for a third term, and the President has commuted Ozy Media founder Carlos Watson's prison sentence.  Makan Delrahim - 18:20Dr. Scott Gottlieb - 29:53 In this episode:Becky Quick, @BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

This week on Face the Nation, as the backlash over the Trump administration's deportation of alleged Venezuelan gang members grows, we talk to White House National Security Adviser Mike Waltz, the head of the Senate Homeland Security Committee Kentucky Republican Rand Paul, and the top Democrat on the House Intelligence Committee Connecticut's Jim Himes. Plus, measle cases have now been reported in 18 states. We consult with former FDA commissioner Dr. Scott Gottlieb about that and the impact of the Trump administration's cuts to medical research. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

President Trump has signed an executive order aimed at dismantling the Department of Education. If Congress approves the dissolution, former U.S. Secretary of Education Margaret Spellings argues that states will need to make up for the data, oversight, and funds that the department currently handles for American students. Former FDA Commissioner Dr. Scott Gottlieb discusses the spread of avian flu and its impact on America's food supply and its egg prices. Plus, the New York Times reported that Elon Musk is headed to the Pentagon, Tesla is weathering protests and vandalism, and Home Depot CEO has weighed in on President Trump's tariffs.  Margaret Spellings - 16:04Dr. Scott Gottlieb - 28:43 In this episode:Dr. Scott Gottlieb, @ScottGottliebMDCameron Costa, @CameronCostaNYMelissa Lee, @MelissaLeeCNBCJoe Kernen, @JoeSquawk

Uncertainty from U.S. tariffs and the DOGE agenda has prompted a volatile week in the financial markets. UK Prime Minister Keir Starmer visited President Trump days ahead of  Ukrainian President Volodymyr Zelenskyy's Washington visit; both leaders have tariffs and war top of mind. In Texas, a child has become America's first measles-related death in almost a decade. Former FDA Commissioner Dr. Scott Gottlieb discusses the measles outbreak risks of declining vaccination rates in certain communities, bringing down the average vaccination rates in some states. Plus, Meta plans to release its own AI app, and it's awards season! Variety's Cynthia Littleton discusses the expected Oscar wins at the 97th Academy Awards this Sunday.   Dr. Scott Gottlieb - 16:36Cynthia Littleton - 27:06 In this episode:Dr. Scott Gottlieb, @ScottGottliebMDJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

Hosts Brad Wright and Kevin Williams are joined by Scott Gottlieb of U.S. Compliance Consultants. Scott is President of U.S. Compliance Consultants, a full-service compliance consulting company that focuses exclusively on state and SEC-registered investment advisers. Scott founded U.S. Compliance Consultants in 2004. U.S. Compliance Consultants has been a preferred service provider for both Schwab and Raymond James almost since its founding and Scott has conducted multiple compliance seminars on a variety of topics for both firms. Prior to founding US Compliance Consultants, Scott was a corporate and securities attorney at Kelly, Drye and Warren, an international law firm based in New York City. He started out as a corporate attorney for Robinson & Cole, a regional law firm with offices in Boston, Hartford and Stamford, CT. They discuss: - The job of an outside compliance consultant -State versus SEC compliance -Launching a new firm -What regulators are focusing on in 2025, including artificial intelligence For more on U.S. Compliance Consultants: https://uscomplianceconsultants.com/  To contact Scott: seg@uscomplianceconsultants.com 

This week on Face the Nation, the president's mission to shrink the federal workforce intensifies, and his foreign policy dealmaking hits a critical juncture. Late Friday, the purge of the federal workforce struck the Pentagon at the top, during a critical moment for our national security, as the new administration seeks peace talks to end Russia's war in Ukraine and as a fragile truce between Israel and Hamas hangs in the balance. We spoke with Trump's top negotiator and envoy, Steve Witkoff. Meanwhile here at home, the president takes aim at Democratic governors who oppose his agenda. We asked New York Governor Kathy Hochul how she's picking her battles with the new administration. Lawmakers are facing some heat from their voters over Trump's push to slash the federal workforce -- led by Elon Musk. Maryland Democrat Chris Van Hollen and Utah Republican John Curtis discuss the impacts on their constituents. Finally, with bird flu, measles and other illnesses on the rise -- and big changes ahead for America's public health agencies, we'll get a reality check from former FDA commissioner Scott Gottlieb. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

UnitedHealth stock fell on a Wall Street Journal report that the DOJ is investigating the insurer's Medicare billing protocol. Former FDA Commissioner Dr. Scott Gottlieb explains the nuances of the health insurance system, and he considers how the Trump administration will handle rising cases of bird flu. And big news from Coinbase: CEO Brian Armstrong says the SEC will drop its case against the company. Armstrong explains his approach to regulation in a new administration, the future of memecoins, and the merit in prediction markets. CNBC's Robert Frank discusses the IRS plan to cut 6% of its workforce. Plus, Meta has approved a plan for bigger bonuses for some executives. Robert Frank - 10:23Dr. Scott Gottlieb - 18:40Brian Armstrong - 32:57 In this episode:Robert Frank, @robtfrankJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

Hamas has postponed its next hostage release, alleging Israel of breaching their ceasefire agreement. Amos Hochstein, former Biden senior advisor and lead broker of the Israel-Lebanon deal, maps out the next incremental steps toward a stable Middle East. In the U.S., a judge has blocked the Trump administration's proposed cuts to the National Institutes of Health's research funding. Dr. Scott Gottlieb addresses the potential impacts of these funding reductions on clinical studies, and he considers potential cuts to the FDA, as well. Elon Musk is leading an investor group's $97.4B offer to take over OpenAI; CEO Sam Altman confirmed to CNBC, he is not taking it seriously. Plus, President Trump has paused enforcement of a law banning US companies from bribing foreign officials, claiming it puts American firms at a disadvantage. Amos Hochstein - 15:49Dr. Scott Gottlieb - 28:34 In this episode:Amos Hochstein, @amoshochsteinDr. Scott Gottlieb, @ScottGottliebMDJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinCameron Costa, @CameronCostaNY

Jason Wright has ended his tenure leading the NFL Washington Commanders and has joined Ariel Investments co-CEO Mellody Hobson in a women's sports investing venture. The venture, Project Level, is a part owner in the newest National Women's Soccer League franchise in Denver. The two leaders discuss investing in women's sports and betting on diversity in boardrooms to boost corporate bottom lines. Plus, President Trump's pick to lead the Department of Health and Human Services appeared on Capitol Hill for two intense days of confirmation hearings. Robert F. Kennedy Jr. answered Senator questions about Medicare, Medicaid, and vaccinations, but former FDA Commissioner and Pfizer board member Dr. Scott Gottlieb said RFK's responses showed a failure to fully grasp the fundamentals of the current healthcare system. Plus, the clock is ticking on President Trump's tariffs on Canada and Mexico. CNBC's Steve Liesman breaks down the economics of the plans.  Steve Liesman - 06:25Dr. Scott Gottlieb - 15:46Mellody Hobson & Jason Wright - 26:55

Dr. Scott Gottlieb is a poster child for the revolving door between government and industry, having served as head of the FDA under Trump before taking a high-paying gig on the board of Pfizer. Asked recently during a segment on CNN whether the COVID vaccine might be responsible for the dramatic spike in cancers in the past few years, Gottlieb predictably hemmed and hawed and sought to deflect blame away from vaccines. Jimmy and Americans' Comedian Kurt Metzger discuss the rank corruption of the government-industry revolving door.  Plus segments on Joe Biden's admission that he's guilty of war crimes and former Congressman and firefighter Curt Weldon's perspective on the government's failures in stopping the LA fires. Also featuring Stef Zamorano and Mike MacRae. Plus a phone call from JD Vance!

Happy New Year! 2025 brings executive turnover to multiple corporate teams, including Apple, which is replacing its CFO, and Disney, where Morgan Stanley's James Gorman is helping find a successor to Bob Iger. Dartmouth Tuck School of Business professor Paul Argenti weighs the succession plans at both companies. And this January, we're in the thick of cold, flu, RSV, and norovirus; former FDA Commissioner Dr. Scott Gottlieb discusses the uptick in illness this winter, as well as potential changes to the U.S. healthcare system. Plus, New York's congestion pricing looms, and deadly incidents in New Orleans and Las Vegas prompted security concerns on New Year's Day. Scott Gottlieb - 13:26Paul Argenti - 25:32 In this episode:Becky Quick, @BeckyQuickJoe Kernen, @JoeSquawkKatie Kramer, @Kramer_Katie

Black Friday is here, and while many shoppers are hitting the malls, others are taking advantage of deals on social media. Marketing and social media expert Gary Vaynerchuk highlights the rise of live shopping on social media as a potential disruption to the retail industry. Influencers are making millions of dollars each month through live shopping events on TikTok, he says, much like QVC. Next, Dr. Scott Gottlieb gives his perspective on the future of health care as President-elect Trump's transition team takes shape, including Trump's pick of RFK Jr. as health secretary. CNBC's wealth reporter Robert Frank shares the impact philanthropy has had on the net worth of America's richest people–and explains why Warren Buffett has already shared his will with his family. Plus, the FTC has launched an antitrust investigation into Microsoft, and Moana 2, Wicked and Gladiator II had a successful Thanksgiving. Dr. Scott Gottlieb - 21:19Gary Vaynerchuk - 34:52 In this episode:Gary Vaynerchuk, @garyveeScott Gottlieb, @ScottGottliebMDBecky Quick, @BeckyQuickSteve Liesman, @steveliesmanRobert Frank, @robtfrankZach Vallese, @zachvallese

Guest: Scott Gottlieb, MD Host: Charles Turck, PharmD, BCPS, BCCCP Patients 50+ with moderate-to-severe plaque psoriasis face adherence challenges, increased risk of comorbidities, and insurance transitions from commercial to Medicare. To learn more about how ILUMYA® (tildrakizumab-asmn) helps address the specific treatment needs of these patients, join Dr. Charles Turck as he speaks with Dr. Scott Gottlieb, a physician at Schweiger Dermatology Group in Exton, Pennsylvania.

The CDC announced a link between McDonald's and a multistate E. coli outbreak. Dr. Scott Gottlieb on what that means for the company and consumers. Morgan sits down with Norfolk Southern CEO Mark George for his first interview in the new role. Starbucks shares slid in Overtime after giving a Q4 warning and suspending its 2025 guidance. Plus, Evernote co-founder Phil Libin on tempering AI expectations. 

Heading into Labor Day Weekend, The Points Guy Brian Kelly explains generational travel trends and airport efficiency. Plus, cases of mosquito-borne viruses are ticking up in the US. Former FDA Commissioner Dr. Scott Gottlieb discusses late summer safety. Dr. Gottlieb is also calling for regulations to ensure safety in medical labs and prevent another pandemic from breaking out.  Brian Kelly - 02:31Dr. Scott Gottlieb - 11:05 In this episode: Leslie Picker, @LesliePickerMike Santoli, @michaelsantoliBrian Sullivan, @SullyCNBCKatie Kramer, @Kramer_Katie

This week on Face the Nation, tensions in the Middle East on the rise again as Israel conducts preemptive strikes against Iranian proxy Hezbollah…Israeli Ambassador to the U.S. Michael Herzog gives us insight into these overnight developments and what could come next in this conflict … Lt. Gen. H.R McMaster, former Trump National Security Advisor, joins us to discuss his new book “At War With Ourselves” and what a second Trump administration's foreign policy could look like… Two Democratic lawmakers, Rep. Pat Ryan and Rep. Summer Lee, discuss what comes next for the Harris-Walz campaign following the Democratic National Convention… Oklahoma Governor Kevin Stitt joins us for a conversation on the presidential candidates' economic policies… Finally, after a late summer surge in Covid-19 infections, Dr. Scott Gottlieb breaks down what we can expect from new vaccines and his recommendations going into the fall.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In the latest chapter of a volatile month for equities, the S&P rallied nearly 4% for its best week since 2023. High prices for basics like eggs are still squeezing consumers, though, and Vice President Kamala Harris has begun to hint at her economic agenda, including federal action to prevent price gouging. She will formally accept the Democratic nomination for President at the Democratic National Convention kicking off Monday in Chicago. Stephen Moore, economic advisor for the Republican nominee Donald Trump, offers his perspective on VP Harris' plans, while Groundwork Collaborative's Lindsay Owens defends the strategy as commonsense. Plus, mpox cases and deaths are rising in the Democratic Republic of the Congo, and the Philippines has detected its first case. Former FDA Commissioner Dr. Scott Gottlieb explains the history of the virus, the treatments for it, and new information on how it spreads.  Lindsay Owens & Stephen Moore 18:30Dr. Scott Gottlieb 33:02 In this episode:Dr. Scott Gottlieb, @ScottGottliebMDJoe Kernen, @JoeSquawkKelly Evans, @KellyCNBCMike Santoli, @michaelsantoliKatie Kramer,@Kramer_Katie

Richard Haass, President Emeritus of the Council on Foreign Relations and Senior Counselor at Centerview Partners, discusses the escalating tensions in the Middle East, critical geopolitical hotspots, and support for Israeli Prime Minister Netanyahu. Former FDA Commissioner Dr. Scott Gottlieb is zeroing in on the opioid crisis; fentanyl claiming over 80,000 American lives each year, and he's urging the U.S. to disrupt the fentanyl trade. Plus, the Financial Times is reporting a secret deal between Google and Meta aimed to target Instagram advertisements at teenagers, and Taylor Swift has canceled her Vienna shows after authorities suspected a plotted attack. Dr. Scott Gottlieb - 14:20Richard Haass - 22:47 In this episode:Richard Haass, @RichardHaassScott Gottlieb, @ScottGottliebMDJoe Kernen, @JoeSquawkAndrew Ross Sorkin,@andrewrsorkinCameron Costa, @CameronCostaNY

In this video, we dive into some jaw-dropping results from a new study that's shaking up the world of AI and medicine. Turns out, PD, an AI language model, absolutely crushed it with a 98% score on 50 questions from the USMLE Step 3 medical licensing exam! That's right—this AI beat out heavyweights like Claude, Gemini, Grok, and Hugging Chat/Slash Llama. We've got Dr. Scott Gottlieb, former FDA Commissioner and CNBC contributor, breaking it all down for us. He reveals a shocking fact: doctors only need a 60% to pass their exams. What's going on there? We also explore how these AI models are more like supercharged search engines rather than true medical experts. While AI can spit out answers like a pro, it doesn't mean it's ready to perform brain surgery anytime soon. But that's not all—we're also diving into some recent stock analysis. We look at Microsoft's performance based on OVTLYR's buy and sell signals. From a solid buy signal on June 14th to a sell signal on July 15th, Microsoft saw a nice 2.5% gain, or about $11 per share. OVTLYR's signals delivered a 113% return, showing just how powerful these tools can be. So, if you're curious about the future of AI in medicine and want to see how tech and trading intersect, this video is for you. Hit that subscribe button and stay tuned for more insights! #AI #MedicalAI #ChatGPT #MedicalExam #OVTLYR #StockMarket #MicrosoftStock #TradingSignals #DrScottGottlieb #AIInsights #InvestmentTips

JD Vance made his first speech as Donald Trump's VP pick at the Republican National Convention; CNBC's Eamon Javers reports on Senator Vance's reception at the RNC in Milwaukee, and former SEC Chair Jay Clayton explains how Vance's new economic conservatism works–or doesn't work–with the Republican preference for Reaganomics. Meanwhile, President Joe Biden has tested positive for Covid-19, but he's still campaigning. Plus, ChatGPT scored a 98% on a medical exam that most first year residents score a 70% on. Former FDA Commissioner Dr. Scott Gottlieb says, some AI LLMs are good at providing differential diagnoses when presented with detailed lab results.  Eamon Javers - 07:30Jay Clayton - 16:56Dr. Scott Gottlieb - 31:04 In this episode:Eamon Javers, @eamonjaversScott Gottlieb, @ScottGottliebMDBecky Quick,@BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin,@andrewrsorkinKatie Kramer,@Kramer_Katie

In the wake of the first Presidential debate, President Biden's campaign is fundraising and rallying support despite a disappointing performance. Andrew Ross Sorkin, CNBC's Megan Cassella, and Axios correspondent Alex Thompson share their respective reporting from different sources across the Democratic party. The Supreme Court has overturned a 1984 decision called ‘Chevron,' which set a precedent for lower courts to defer to federal agencies when interpreting ambiguities in laws passed by Congress. Former FDA Commissioner Dr. Scott Gottlieb explains what work the FDA has done under Chevron, and he outlines the challenges that lie ahead, after the new ruling. Plus, the summer box office is ‘Inside Out' and heating up, and so are politics in France. Megan Cassella - 13:15Alex Thompson -  15:56Dr. Scott Gottlieb - 28:35 In this episode:Megan Cassella, @mmcassellaDr. Scott Gottlieb, @ScottGottliebMDAlex Thompson, @AlexThompBecky Quick,@BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin,@andrewrsorkinKatie Kramer,@Kramer_Katie

Senator Elizabeth Warren (D-MA) is taking on big banks and Federal Reserve Chair Jay Powell, to whom she says, “do your job.” She has a spirited conversation with Becky Quick and Joe Kernen about the Fed, the banking system, and tax code fairness. And after the Surgeon General's warning on social media's harm to kids, former FDA Commissioner Dr. Scott Gottlieb discusses the science proving social media's toll on teens, and he compares Congress's strategy today with the FDA's strategy navigating illicit opioid sales on social media, years ago. Plus, CNBC's Emily Wilkins reports on the boom of “revenge porn” deepfakes, Apple will stop offering buy now, pay later loans in the U.S., and some victims of the AI craze: Chegg stock is down 90% since OpenAI's launch of ChatGPT.  Sen. Elizabeth Warren - 10:36Dr. Scott Gottlieb - 28:26 In this episode:Sen. Elizabeth Warren, @SenWarrenJoe Kernen, @JoeSquawkBecky Quick,@BeckyQuickKatie Kramer,@Kramer_Katie

Apple showed off its long-awaited AI integration—dubbed Apple Intelligence—at the WWDC today in Cupertino. We break down all the angles you need to know. Plus, Dr. Scott Gottlieb on Eli Lilly's Alzheimer's drug getting FDA recommended and former United Airlines CEO on the road ahead for the Southwest CEO after Elliott Management revealed a stake in the airliner. Janus Henderson portfolio manager Jeremiah Buckley on how the next leg of the bull market could unfold.

Dr. Scott Gottlieb returns! The former FDA Commissioner gives us a deep dive into the revolutionary advances in cell/gene therapies and other treatments that have the potential to cure cancer, reverse aging, and re-engineer our DNA. We also discuss the emerging role of AI in healthcare and get a bit wonky discussing regulatory hurdles at the FDA. A must-listen for anyone interested in the future of healthcare, the impact of policy on medical innovation, and the exciting possibilities of gene and cell therapy.  Dr. Scott Gottlieb served as the twenty-third commissioner of the FDA under President Trump. He is a resident fellow at the American Enterprise Institute and author of the forthcoming book “The Miracle Century: Making Sense of the Cell Therapy Revolution.” Follow him on X at @ScottGottliebMD.

Former President Donald Trump's political allies are crafting a plan to increase his influence over the Federal Reserve, potentially even making him an "acting" member of the central bank's board, according to The Wall Street Journal. Nick Timiraos, the Journal's Chief Economics Correspondent, discusses the implications if Trump wins in November. Former FDA Commissioner Dr. Scott Gottlieb weighs in on Moderna's partnership with OpenAI, the AI drug revolution, his own AI venture, and updates on the bird flu presence in America's pasteurized milk. Plus, CNBC's Steve Kovach breaks down Alphabet and Microsoft earnings and explores the future of AI investment for the megacap tech companies. Nick Timiraos - 10:08Steve Kovach - 17:22Dr. Scott Gottlieb - 22:12.In this episode:Nick Timiraos, @NickTimiraosScott Gottlieb, @ScottGottliebMDJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickAndrew Ross Sorkin, @andrewrsorkinZach Vallese, @zachvallese

Robinhood has unveiled its first credit card, and it's made of gold. CEO Vlad Tenev shares details of his company's foray into credit, and he weighs in on Elon Musk's hopes for payment processing on X, as well as meme stock mania. The FDA has approved Merck's treatment for a rare lung and cardiovascular condition, but the drug's launch price is steep. Former FDA Commissioner and board member at Pfizer and Illumina Dr. Scott Gottlieb discusses the pressures and mandatory discounts that factor into drug pricing. Plus, Elon Musk's Neuralink has enabled a person with paralysis to play chess online, but one lawmaker is raising concerns about whether the brain implant should have been approved for human testing so quickly.  And, the latest on the Baltimore bridge collapse, Gamestop's miss and the NFL starts early on holiday planning. Vlad Tenev - 14:06Scott Gottlieb - 29:37 In this episode: Vlad Tenev, @vladtenevJoe Kernen, @JoeSquawkBecky Quick, @BeckyQuickKatie Kramer: @Kramer_Katie

Apple is winding down its electric car strategy after 10 years of quiet work. Apple is also reportedly making a last effort to avert an antitrust probe. UnitedHealth, owner of the largest insurer in the U.S., is facing an antitrust probe of its own. Former FDA Commissioner Dr. Scott Gottlieb argues that consolidation in the industry is partly a consequence of hospitals and physicians losing money on Medicare. Starbucks and Workers United are making progress. Unionized Starbucks employees will now receive the wage hikes their nonunion colleagues received in 2022. Plus, AI is coming for every industry and every workplace. Former head of HR for Goldman Sachs Edith Cooper discusses the risks of new technology and the value that human workers still offer.  Dr. Scott Gottlieb - 16:48Edith Cooper - 25:14 In this episode:Scott Gottlieb, @ScottGottliebMDJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinMelissa Lee, @MelissaLeeCNBCKatie Kramer, @Kramer_Katie

Needham is upgrading Disney to buy for the first time in five years. The analyst behind that call joins us with what's behind the decision. Plus, the S&P is nearing a record but our guest is bargain hunting in the beaten-down parts of the market and brings us his favorite names. And Philip Morris' fastest-growing, tobacco-free product is facing some criticism from Capitol Hill. We'll speak to an analyst about what it means for the stock, and former FDA Commissioner Dr. Scott Gottlieb for the impact on consumers.

2024 trading begins after a strong market finish to 2023, with the Nasdaq 100 closing its best year since 1999. Just over 300 days before the 2024 election, former Connecticut Senator Joe Lieberman is pushing for an option outside of President Biden and President Trump. Once on the Presidential ticket himself, Lieberman started nonprofit No Labels, which hopes to offer a third, bipartisan, centrist “unity ticket” to the Americans unsatisfied with the current political playing field. Plus 2023 was the year of weight loss drugs for pharma companies like Novo Nordisk and Eli Lilly. Former FDA Commissioner Dr. Scott Gottlieb sits on the boards of Illumina and Pfizer, and he expects more good news–and more secondary benefits–from weight loss drugs on the market. Plus, Michigan is celebrating a big sports weekend, and X is now worth 71.5% less than when Elon Musk bought it, according to Fidelity, one of the co-investors that backed his takeover. Joe Lieberman - 12:30Dr. Scott Gottlieb - 24:46 In this episode: Scott Gottlieb, @ScottGottliebMDBecky Quick, @BeckyQuickRobert Frank, @robtfrankMichael Santoli, @michaelsantoliKatie Kramer, @Kramer_Katie

Occidental Petroleum will buy CrownRock for $12 billion, deepening its foothold in the Permian basin. Energy expert and author of “The New Map: Energy, Climate and the Clash of Nations” Daniel Yergin explains what the recent flurry of oil industry mergers means for geopolitics. The FDA has approved treatment for sickle cell disease, the first treatment to use the gene-editing tool CRISPR. Former FDA Commissioner Dr. Scott Gottlieb discusses a treatment's journey from lab to patients, as well as improving the public's access to life-saving care. Plus, Macy's has a $5.8 billion buyout offer, and University of Pennsylvania's President Elizabeth Magill has resigned after her controversial testimony on Capitol Hill last week. Daniel Yergin - 15:38Dr. Scott Gottlieb - 23:50 In this episode: Dan Yergin, @danielyerginScott Gottlieb, @ScottGottliebMDMichael Santoli, @michaelsantoliAndrew Ross Sorkin, @andrewrsorkinBecky Quick, @BeckyQuickKatie Kramer, @Kramer_Katie

–Monday December 4th 2023—   —Here are 3 big things you need to know—   One — The Iranian-backed Houthis are claiming responsibility for attacks on three commercial ships in the Red Sea Sunday.  The USS Carney shot down several drones that officials say were launched from Houthi-controlled parts of Yemen, just a month after it shot down rockets and drones fired by Houthi militants.  U.S. Central Command said that the attacks represent a direct threat to international commerce and maritime security.     Two—  The strike at the MGM Grand Detroit Casino is over after 47-days.  The union has ratified the contract with the casino after they voted down a tentative deal last month.  The Detroit Casino Council says it includes an immediate 18-percent pay raise on average and has the largest-ever wage increases.      And number three — A leading national health expert says the U.S. should experience a more typical flu and virus season this winter.  Speaking on CBS' Face the Nation, former FDA Commissioner Dr. Scott Gottlieb says the level of RSV and flu cases is abating, compared to epidemic numbers in past years.  He added the number of COVID cases are down from past years.  

This week on Face the Nation, US officials step up their pressure on Israel to do more to protect civilians as the Israeli offensive resumes. We have the latest on the conflict, plus we'll talk with House Intelligence Committee Chairman Mike Turner about his concerns about our own ability to prevent attacks here in the US. Six weeks out from the first votes in the 2024 presidential contest, we talk to GOP candidate and former New Jersey Governor Chris Christie. And former FDA head Dr. Scott Gottlieb is back to talk about the spike in respiratory illnesses among children.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Federal Reserve's Jackson Hole meeting is over, but chair Jay Powell's comments there are still echoing through the markets. Allianz Chief Economic Advisor Mohamed El Erian digests Powell's Wyoming speech, including his comments that inflation is still too high, and his choice to leave the door open for more rate hikes in the future. U.S. Commerce Secretary Gina Raimondo is in China this week, meeting top officials in an effort to pursue a more stable relationship with the CCP. CNBC's Beijing Bureau Chief Eunice Yoon reports from China on the local response to Sec. Raimondo's visit, and what Chinese officials expect to get from the meetings. Plus, the Biden administration is poised to negotiate costs of Medicare drugs directly with pharmaceutical companies. Former FDA Commissioner Scott Gottlieb discusses the impact of these negotiations and the complications still ahead to lower prescription prices.  Eunice Yoon - 11:46Mohamed El Erian - 17:46Dr. Scott Gottlieb - 28:27 In this episode:Eunice Yoon, @onlyyoontvScott Gottlieb, MD, @ScottGottliebMDMichael Santoli, @michaelsantoliRobert Frank, @robtfrankJoe Kernen, @JoeSquawkKatie Kramer, @Kramer_Katie

This week on Face the Nation, yet another extraordinary severe weather event with a West Coast Hurricane, and Republican presidential candidates prepare for the first debate -- without Donald Trump. As the recovery efforts continue in Maui, the questions about the state and local response continue to grow, we spoke exclusively with Hawaii's governor Joshua Green. Plus, with coronavirus cases on the rise, former FDA Commissioner Dr. Scott Gottlieb will tell us what we need to know about the new arsenal of fall vaccines to fight covid, the flu, and RSV.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Target slashed its sales and profit expectations in its latest quarterly report. CNBC's Courtney Reagan and Forrester Research's Sucharita Kodali explain the retailer's troubles, from inflation-conscious shoppers to Pride month backlash. A new strain of Covid-19 is hitting the American South and West; former FDA Commissioner Dr. Scott Gottlieb explains the risks, the relevance of vaccinations and boosters for immunity, and this phase of endemic Covid. Plus, there are new court filings in the federal case against FTX founder Sam Bankman-Fried, a new deal could breathe life into Wheels Up stock, X Corp. has rebranded Tweetdeck, and Cava is hoping to satisfy Wall Street's appetite.  Sucharita Kodali - 15:17Courtney Reagan - 11:44Dr. Scott Gottlieb - 24:09 In this episode:Sucharita Kodali, @smulpuruScott Gottlieb, MD, @ScottGottliebMDCourtney Reagan, @courtreaganMelissa Lee, @MelissaLeeCNBCJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinKatie Kramer, @Kramer_Katie

Another big box office weekend, in the books. Puck founder and entertainment journalist Matt Belloni recaps the latest ‘Barbenheimer' hype, strikes in Hollywood, and Disney's most recent disappointment. Belloni also discusses his latest scoop: Disney CEO Bob Iger has brought in two former heirs apparent, for consultation on the company's next chapter. AI is breaking into health care. Former FDA Commissioner Dr. Scott Gottlieb considers whether AI-powered bots could take on some of a doctor's duties. He discusses how the AI strategies of Amazon, Google, and Microsoft could affect patient care and medical office administration, and what the timeline for those changes might be. Plus, Heineken's beer volumes are down in a key region, and Minneapolis Fed President Neel Kashkari is speaking out on the economy's “soft landing.”In this episode:Scott Gottlieb, MD, @ScottGottliebMDMatthew Belloni, @MattBelloniAndrew Ross Sorkin, @andrewrsorkinBecky Quick, @BeckyQuickKatie Kramer, @Kramer_Katie

Former FDA Commissioner Scott Gottlieb, MD returns to look at the systemic problems within the CDC and how we might fix them. He describes how the agency's bureaucratic glut, mission creep, and lack of transparency contributed to the disastrous COVID-19 response and America's loss of trust in its public health institutions. Later in the episode we turn focus to the FDA and reforming its approval process for innovative drugs and technologies, and end with a conversation about drug pricing reforms. Scott Gottlieb, MD, is the author of "Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic." He is a resident fellow at the American Enterprise Institute. From 2017 to 2019 he served as the 23rd commissioner of the Food and Drug Administration. Dr. Gottlieb is also a special partner with the venture capital firm New Enterprise Associates and serves on the boards of Pfizer, Illumina, Aetion, and Tempus. Follow him on Twitter at @ScottGottliebMD.

The Rich Zeoli Show- Full Episode (03/06/2023): 3:05pm- According to The New York Post's Miranda Devine, “[n]ew emails uncovered by House Republicans probing the COVID-19 pandemic reveal the deceptive nature of Dr. Anthony Fauci.” In early 2020, Fauci commissioned a paper to “disprove the theory that the virus leaked from a lab in Wuhan, China.” You can read the opinion editorial here: https://nypost.com/2023/03/05/new-emails-show-fauci-commissioned-paper-to-disprove-wuhan-lab-leak-theory/ 3:30pm- Appearing on Fox News with Maria Bartiromo, Congressman Jim Jordan (R-OH) addressed allegations that Dr. Anthony—as Director of the National Institute of Allergy and Infectious Disease—pushed researchers to disprove the laboratory leak theory. Rep. Jordan called for greater transparency immediately. 3:40pm- While speaking with Margaret Brennan, former FDA Commissioner Dr. Scott Gottlieb said, “I think we should work under the assumption that there is a probability [the COVID-19 pandemic] was a lab leak…we ought to look into outlawing that kind of research…or conduct it in… high security labs.” 3:50pm- Former Secretary of State Mike Pompeo told Fox News' Shannon Bream that he has no doubt that COVID-19 originated from a laboratory leak in Wuhan, China and accused Dr. Anthony Fauci of being “complicit” in its cover-up. 4:05pm- Speaking at the 2023 Conservative Political Action Coalition (CPAC) taking place outside of Washington, D.C., former President Donald Trump referred to the World Health Organization (WHO) as “We Hide Outbreaks.” Trump also told members of the press that China needs to be held accountable for the COVID-19 outbreak, accusing China of costing the world economy an estimated $50 trillion in economic growth. 4:10pm- On Sunday, Florida Governor Ron DeSantis spoke at the Ronald Reagan Presidential Library in Ventura, California. During his speech, in front of a packed crowd, Gov. DeSantis criticized California Governor Gavin Newsom, Disney, and woke ideology. 4:15pm- Former United States Ambassador to the United Nations Nikki Haley spoke at the 2023 Conservative Political Action Coalition (CPAC) taking place outside of Washington, D.C. over the weekend. Her speech was not well attended—is she just campaigning to be the eventual Republican Presidential nominee's Vice President? 4:35pm- According to The New York Post, the Minnesota Department of Human Rights has ordered USA Powerlifting to permit biological males who identify as female to compete in the women's division. 4:55pm- New York City Mayor Eric Adams is now telling citizens to remove their face masks when entering a store—in hopes of cracking down on shoplifting. 5:05pm- The Drive at 5: According to a report from Ari Blaff at National Review, “Southern Poverty Law Center (SPLC) staff attorney Thomas Jurgens was among the dozens of rioters arrested following a violent attack on police at the proposed site of the Atlanta Police Foundation's training facility, located a few miles south of the city.” The Southern Poverty Law Center is notorious for inaccurately labeling mundane conservative organizations as dangerous, hate groups. You can read the report at: https://www.nationalreview.com/news/dozens-arrested-for-attacking-cops-with-molotov-cocktails-bricks-at-atlanta-training-facility/?utm_source=email&utm_medium=breaking&utm_campaign=newstrack&utm_term=30748108 5:20pm- In response to Hershey's decision to go “woke”, The Daily Wire has released its own brand of chocolate and has already sold over 300,000 candy bars in the first 36-hours of their release. 5:35pm- According to reports, author R.L. Stine intends to edit his “Goosebump” books to have more inclusive language. 5:40pm- Comedian Chris Rock addressed Will Smith's 2022 Oscars slap during a live Netflix stand-up special on Saturday. 6:05pm- A New York Times opinion editorial by David Wallace-Wells theorizes that “we've been talking about the lab-leak hypothesis all wrong.” Wallace-Wells writes, “if you had been told, back in 2019, that this would be the state of knowledge in 2023, would it not seem extremely weird to you that there has not been a broad public conversation about the wisdom of potentially dangerous virological research in the meantime? That so much more oxygen had been eaten up by partisan theater than by public debate over the policy implications of such a possibility?... The boundaries of mainstream discourse have suggested that we should resolve the matter of pandemic origins before moving on to the implications of the lab-leak hypothesis. But this has proved a paralyzing standard.” You can read the editorial here: https://www.nytimes.com/2023/02/28/opinion/lab-leak-energy-department-covid.html 6:30pm- A New York Times opinion-columnist says he can no longer enjoy McDonald's because his socio-economic status has changed after attending Yale—and, consequently, fast food is now beneath him. 6:45pm- Russell Brand accuses MSNBC of bias while on HBO's Real Time with Bill Maher. FLASHBACK: MSNBC's greatest lies!

The Rich Zeoli Show- Hour 1: According to The New York Post's Miranda Devine, “[n]ew emails uncovered by House Republicans probing the COVID-19 pandemic reveal the deceptive nature of Dr. Anthony Fauci.” In early 2020, Fauci commissioned a paper to “disprove the theory that the virus leaked from a lab in Wuhan, China.” You can read the opinion editorial here: https://nypost.com/2023/03/05/new-emails-show-fauci-commissioned-paper-to-disprove-wuhan-lab-leak-theory/ Appearing on Fox News with Maria Bartiromo, Congressman Jim Jordan (R-OH) addressed allegations that Dr. Anthony—as Director of the National Institute of Allergy and Infectious Disease—pushed researchers to disprove the laboratory leak theory. Rep. Jordan called for greater transparency immediately. While speaking with Margaret Brennan, former FDA Commissioner Dr. Scott Gottlieb said, “I think we should work under the assumption that there is a probability [the COVID-19 pandemic] was a lab leak…we ought to look into outlawing that kind of research…or conduct it in… high security labs.” Former Secretary of State Mike Pompeo told Fox News' Shannon Bream that he has no doubt that COVID-19 originated from a laboratory leak in Wuhan, China and accused Dr. Anthony Fauci of being “complicit” in its cover-up.

House Republicans are following through on their promises and going after the IRS, but will the Swamp ever truly be able to fix itself? Classified documents from the Obama era related to Ukraine, Iran, and the U.K. have been found in President Biden's old office at the Penn Biden Center. Will a SWAT team raid the think tank like one did Mar-a-Lago? The Biden administration is considering a nationwide ban on gas stoves. New guidelines from the American Academy of Pediatrics suggest that parents should fight childhood obesity with medication and surgery. The latest "Twitter Files" release exposes how Pfizer board member and former FDA commissioner Dr. Scott Gottlieb tried to get Twitter to censor criticism of the COVID vaccines. Failed gubernatorial candidate Stacey Abrams announced she will likely run for office again. Today's sponsors: Bank On Yourself is a better way to grow and protect your hard-earned money. Get a FREE report with all the details on how the Bank On Yourself strategy adds guarantees, predictability, and control to your financial plan. Just go to https://BankOnYourself.com/MATTERS Grove creates and curates everything you need for a sustainable home. Go to https://Grove.com/news today to get a FREE starter set plus FREE shipping with your first order! Learn more about your ad choices. Visit megaphone.fm/adchoices

Megyn Kelly is joined by Robert F. Kennedy, Jr., author of "A Letter to Liberals," to discuss COVID pandemic orthodoxy, the need for discussion and debate, the elimination of freedoms due to the COVID pandemic, Dr. Fauci demanding blind faith in authority, the important issue of whether the COVID vaccines prevent transmission, myocarditis risk from COVID and from vaccines, rise in "unexplained" deaths in a post-COVID vaccine world, the truth about how many lives COVID vaccines saved and lost, the lack of important data needed to understand the rise in deaths post-COVID, what Fauci said about vaccines that could have an adverse effect before the COVID vaccines were available, the absurdity of the new booster which was only tested on eight mice and no humans, Pfizer's involvement in the Trump administration, Alex Berenson and tech censorship, RFK's disbanded "vaccine safety" commission, Scott Gottlieb and our supposed medical elite, American Academy of Pediatrics' recommendations, problems with the VAERS system, personal backlash from family and friends, his views of Donald Trump then and now, Herschel Walker and our politics today, the war in Ukraine, American imperialism, RFK's personal connection to the war as his son Conor was fighting in the country, and more.Alternately, here's the CDC on vaccines:https://www.cdc.gov/vaccines/index.htmlhttps://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.htmlFollow The Megyn Kelly Show on all social platforms: YouTube: https://www.youtube.com/MegynKellyTwitter: http://Twitter.com/MegynKellyShowInstagram: http://Instagram.com/MegynKellyShowFacebook: http://Facebook.com/MegynKellyShow Find out more information at: https://www.devilmaycaremedia.com/megynkellyshow